Comparing the effects of two medications for high cholesterol

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the pharmacokinetic characteristics and safety profiles of two medications, AD-228B and AD-2284, in healthy volunteers. The primary goal is to determine how these drugs are absorbed, distributed, metabolized, and excreted in the body. Participants will be monitored for safety and any adverse effects during the study. The findings will help inform future treatments for primary hypercholesterolemia.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
* The Age equal to or greater than 19 in healthy volunteers at the time of screening visit

Exclusion Criteria:

* Participation in other clinical study with an investigational drug within the 6 months from scheduled first administration
* Other exclusions applied

Where it's running

• H Plus Yangji Hospital
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: JeongEun Park
• Email: parkje@addpharma.co.kr
• Phone: +82-31-891-6989

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Bempedoic Acid With Ezetiimibe in Adults with High Cholesterol or Mixed Dyslipidemia

  This study tests bempedoic acid alone or with ezetimibe in real-world adults with primary hypercholesterolemia or mixed dyslipidemia to see how safe and effective it is in routine care.

  Recruiting at 38 sites Daiichi Sankyo · Belo Horizonte and 37 other locations · NCT07206472

• Safety and how the body handles AD-116 and AD-1161 in healthy adult men

  This will test how safe AD-116 and AD-1161 are and how the body processes them in healthy adult men after a meal.

  Recruiting Phase 1 Addpharma Inc. · Seoul · NCT07444385

• Single-dose safety and blood-level comparison of AD-115A versus AD-1151 in healthy adults

  This test will see if a single dose of AD-115A or AD-1151 is safe and how each drug is absorbed and cleared in healthy adults.

  Recruiting Phase 1 Addpharma Inc. · Seoul · NCT07385235

• Comparing the effects of two medications on healthy individuals

  This study tests how two medications work in healthy people to see if one is safer or more effective than the other.

  Recruiting Phase 1 Addpharma Inc. · Seoul · NCT06932705

• Evaluating the effects of two medications for high blood pressure

  This study is testing whether a combination of two new medications can help people with high blood pressure feel better and stay safe.

  Recruiting Phase 3 Addpharma Inc. · Seoul · NCT06441630

• Evaluating the effectiveness and safety of AD-218 for mixed dyslipidemia

  This study is testing if a new drug called AD-218 can help people with mixed dyslipidemia improve their cholesterol levels and overall health.

  Recruiting Phase 3 Addpharma Inc. · Daegu, Nam-gu · NCT05400317

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.